Paraguay
Diabetes country report 2000 — 2050
Skip Map
Number of adults (20–79 years) with diabetes in Paraguay (PY)
2000 | 120.8 thousand |
2011 | 205.0 thousand |
2024 | 352.2 thousand |
2050 | 610.0 thousand |
Paraguay is one of the 19 countries and territories in the IDF South and Central America Region.
Data source(s) used for the diabetes estimates in adults:
- Estimates extrapolated from Argentina, Brazil, Chile, Costa Rica, Cuba, Panama and Uruguay.
2000
2011
2024
2050
Loading...
Diabetes estimates (20-79 y) | ||||
---|---|---|---|---|
People with diabetes, in 1,000s | 120.8 | 205.0 | 352.2 | 610.0 |
Age-standardised prevalence of diabetes, % | - | 6.5 | 9.4 | 11.0 |
Proportion of people with undiagnosed diabetes, % | - | - | 33.2 | - |
People with undiagnosed diabetes, in 1,000s | - | - | 116.8 | - |
Impaired Fasting Glucose (IFG) | ||||
---|---|---|---|---|
People with IFG, in 1,000s | - | - | 326.3 | 535.4 |
Age-standardised prevalence of IFG, % | - | - | 8.2 | 9.3 |
Impaired Glucose Tolerance (IGT) | ||||
---|---|---|---|---|
People with IGT, in 1,000s | - | 190.4 | 375.8 | 621.8 |
Age-standardised prevalence of IGT, % | - | 5.8 | 9.5 | 10.8 |
Mortality attributable to diabetes (20-79 y) | ||||
---|---|---|---|---|
Deaths attributable to diabetes | - | 2,005.0 | 2,558.0 | - |
Proportion of diabetes-related deaths in people 20-79 y, % | - | - | 9.8 | - |
Hyperglycaemia in pregnancy (HIP) (20-49 y) | ||||
---|---|---|---|---|
Live births affected by HIP | - | - | - | - |
Prevalence of gestational diabetes mellitus (GDM), % | - | - | - | - |
Live births affected by other types of diabetes first detected in pregnancy | - | - | - | - |
Live births affected by other types of diabetes detected prior to pregnancy | - | - | - | - |
Diabetes-related health expenditure | ||||
---|---|---|---|---|
Total diabetes-related health expenditure, USD million | - | - | 519.4 | 746.3 |
Total diabetes-related health expenditure, ID million | - | - | 1,213.3 | 1,743.4 |
Diabetes-related health expenditure per person, USD | - | 284.0 | 1,474.7 | 1,223.4 |
Diabetes-related health expenditure per person, ID | - | - | 3,444.9 | 2,858.0 |
Type 1 diabetes estimates in children and adolescents | ||||
---|---|---|---|---|
People with type 1 diabetes (all age groups) | - | - | 5,930.0 | - |
People with type 1 diabetes (0-19 y) | - | - | 1,610.4 | - |
Demographics | ||||
---|---|---|---|---|
Total adult population (20-79 y), in 1,000s | 2,693.0 | 3,648.5 | 4,284.1 | 5,884.7 |
Population of children and adolescents (0-19 y) | - | - | 2,567,829.0 | - |
Loading...
Diabetes estimates (20-79 y) | |
---|---|
People with diabetes, in 1,000s | 120.8 |
Age-standardised prevalence of diabetes, % | - |
Proportion of people with undiagnosed diabetes, % | - |
People with undiagnosed diabetes, in 1,000s | - |
Impaired Fasting Glucose (IFG) | |
---|---|
People with IFG, in 1,000s | - |
Age-standardised prevalence of IFG, % | - |
Impaired Glucose Tolerance (IGT) | |
---|---|
People with IGT, in 1,000s | - |
Age-standardised prevalence of IGT, % | - |
Mortality attributable to diabetes (20-79 y) | |
---|---|
Deaths attributable to diabetes | - |
Proportion of diabetes-related deaths in people 20-79 y, % | - |
Hyperglycaemia in pregnancy (HIP) (20-49 y) | |
---|---|
Live births affected by HIP | - |
Prevalence of gestational diabetes mellitus (GDM), % | - |
Live births affected by other types of diabetes first detected in pregnancy | - |
Live births affected by other types of diabetes detected prior to pregnancy | - |
Diabetes-related health expenditure | |
---|---|
Total diabetes-related health expenditure, USD million | - |
Total diabetes-related health expenditure, ID million | - |
Diabetes-related health expenditure per person, USD | - |
Diabetes-related health expenditure per person, ID | - |
Type 1 diabetes estimates in children and adolescents | |
---|---|
People with type 1 diabetes (all age groups) | - |
People with type 1 diabetes (0-19 y) | - |
Demographics | |
---|---|
Total adult population (20-79 y), in 1,000s | 2,693.0 |
Population of children and adolescents (0-19 y) | - |